GlassScriptPhysician profile
Pramod Gaudel
NPI 1235506825
$9,471.50
in general payments reported to CMS, 2019-2025
72 companies · $4,020 in 2025
The $4,020 reported for 2025 was more than what 79% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.31 · 2022: $749 · 2023: $507 · 2024: $4,175 · 2025: $4,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,647 · Education: $55.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,646.83 |
| Education | $55.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $678.82 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $661.85 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $651.44 | 2022-2025 | Tagrisso, Enhertu, Lynparza |
| Abbvie INC. | $505.88 | 2022-2025 | |
| Daiichi Sankyo INC. | $482.36 | 2021-2025 | Enhertu, Injectafer |
| Genentech USA, INC. | $432.00 | 2022-2025 | Venclexta, Polivy, Tecentriq |
| Celgene Corporation | $430.34 | 2022-2025 | Reblozyl, Pomalyst |
| Takeda Pharmaceuticals U.S.A., INC. | $374.04 | 2023-2025 | Ninlaro, Alunbrig, Iclusig |
| Genzyme Corporation | $321.44 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $311.88 | 2024-2025 | |
| Glaxosmithkline, LLC. | $299.37 | 2022-2025 | Ojjaara, Jemperli, Zejula |
| Novartis Pharmaceuticals Corporation | $256.76 | 2022-2025 | |
| Astellas Pharma US INC | $191.90 | 2022-2025 | Padcev, Xtandi |
| Alexion Pharmaceuticals, INC. | $189.51 | 2022-2025 | Ultomiris |
| Janssen Biotech, INC. | $187.92 | 2022-2025 | Darzalex, Talvey, Rybrevant |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $176.42 | 2024-2025 | Libtayo |
| Eisai INC. | $165.58 | 2022-2025 | |
| Sobi, INC | $159.48 | 2024-2025 | |
| Incyte Corporation | $152.99 | 2022-2025 | Monjuvi, Jakafi, Zynyz |
| Stemline Therapeutics INC. | $140.41 | 2022-2025 | Elzonris, Orserdu |
| Adaptive Biotechnologies Corporation | $130.22 | 2023-2025 | Clonoseq |
| Pharmaessentia USA Corporation | $120.10 | 2024-2025 | Besremi |
| Adc Therapeutics America, INC. | $108.70 | 2023-2025 | |
| Puma Biotechnology, INC. | $108.06 | 2024-2025 | |
| Lilly USA, LLC | $107.74 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Array Biopharma INC | $102.86 | 2024-2025 | Braftovi, Mektovi, Tukysa |
| Exelixis INC. | $101.93 | 2024-2025 | Cabometyx |
| Bayer Healthcare Pharmaceuticals INC. | $100.65 | 2025 | |
| Rigel Pharmaceuticals, INC. | $99.08 | 2022-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Beone Medicines USA, INC. | $95.72 | 2025 | Tevimbra, Brukinsa |
| Dendreon Pharmaceuticals LLC | $93.68 | 2024-2025 | Provenge |
| Karyopharm Therapeutics INC. | $88.20 | 2022-2024 | Xpovio |
| Gilead Sciences, INC. | $85.07 | 2022-2024 | |
| Emd Serono, INC. | $72.59 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $66.03 | 2024-2025 | Danziten, Vivimusta |
| Beigene USA, INC. | $65.53 | 2024-2025 | Tevimbra, Brukinsa |
| Coherus Oncology, INC. | $63.82 | 2024-2025 | Loqtorzi |
| Geron Corporation | $61.83 | 2024-2025 | Rytelo |
| Kite Pharma, INC. | $56.53 | 2025 | Yescarta |
| Amgen INC. | $53.86 | 2022-2025 | Evenity, Prolia |
| Servier Pharmaceuticals LLC | $53.00 | 2022-2024 | |
| Aveo Pharmaceuticals, INC. | $46.46 | 2022-2025 | |
| Deciphera Pharmaceuticals INC. | $46.44 | 2024 | Qinlock, Tgct |
| Janssen Pharmaceuticals, INC | $44.07 | 2024-2025 | Erleada, Rybrevant |
| Recordati_rare_diseases_inc. | $41.55 | 2024-2025 | Enjaymo, Sylvant |
| Blueprint Medicines Corporation | $39.89 | 2022-2023 | Ayvakit |
| Genmab U.S., INC. | $39.27 | 2023-2024 | Epkinly, Tivdak |
| Iovance Biotherapeutics, INC. | $38.80 | 2025 | Amtagvi |
| Legend Biotech USA INC. | $36.51 | 2024-2025 | Carvykti |
| Seagen INC. | $36.31 | 2022-2023 | Tukysa |
| Fennec Pharmaceuticals, INC. | $32.15 | 2025 | Fyarro |
| Tersera Therapeutics LLC | $31.70 | 2024 | Zoladex |
| Sun Pharmaceutical Industries INC. | $31.61 | 2025 | |
| Apellis Pharmaceuticals, INC. | $31.13 | 2023 | Empaveli |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.06 | 2024 | |
| Taiho Oncology, INC. | $27.65 | 2025 | |
| Sumitomo Pharma America, INC. | $25.81 | 2025 | Orgovyx |
| Acrotech Biopharma INC. | $25.64 | 2024 | Beleodaq |
| Mirati Therapeutics, INC. | $24.82 | 2024 | Krazati |
| Spectrum Pharmaceuticals INC. | $24.00 | 2025 | Rolvedon |
| Ipsen Biopharmaceuticals, INC | $23.52 | 2024 | Onivyde |
| Tempus Ai, INC | $21.43 | 2025 | Xt Cdx |
| Immunocore Limited | $21.40 | 2024 | Kimmtrak |
| Cti Biopharma Corp. | $20.59 | 2023 | Vonjo |
| Springworks Therapeutics, INC. | $20.24 | 2025 | Gomekli |
| Syndax Pharmaceuticals, INC. | $18.37 | 2025 | |
| Myriad Genetic Laboratories, INC. | $16.61 | 2024 | Myrisk |
| Pharmacyclics LLC, An Abbvie Company | $15.74 | 2022 | |
| Accord Healthcare, INC. | $15.21 | 2025 | |
| Octapharma USA, INC. | $13.62 | 2023 | Octagam Immune Globulin (Human) |
| Mylan Institutional INC. | $12.88 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $12.43 | 2022 |
Drugs and devices associated with these payments
Keytruda $635Enhertu $375Reblozyl $344Zepzelca $312Venclexta $307Tukysa $294Imbruvica $293Sarclisa $263Padcev $234Lynparza $219Epkinly $212Ojjaara $205Ibrance $186Libtayo $176Ultomiris $173Lenvima $152Tagrisso $152Xtandi $140Clonoseq $130Braftovi $129Besremi $120Ninlaro $119Kisqali $114Polivy $110Tecentriq $109Mektovi $103Cabometyx $102Rybrevant $101Nubeqa $101Elrexfio $99.59Talvey $98.46Darzalex $98.46Orgovyx $97.48Alunbrig $95.07Phesgo $94.76Provenge $93.68Talzenna $92.85Welireg $92.30Verzenio $91.46Jaypirca $91.46Vonjo $89.25Tevimbra $88.00Iclusig $85.93Rezlidhia $83.12Tavalisse $83.12Jemperli $79.81Monjuvi $74.81Fruzaqla $74.41Brukinsa $73.25Zynlonta $72.21Jakafi $71.18Lutathera $70.94Inlyta $70.50Retevmo $68.52Elzonris $67.23Xpovio $66.28Columvi $65.46Lunsumio $65.46Rytelo $61.83Zejula $60.06Adcetris $58.38Yescarta $56.53Alecensa $56.37Pomalyst $56.13Pluvicto $53.73Danziten $51.80Orserdu $50.81Synagis $48.86Calquence $46.99Qinlock $46.44Injectafer $45.03Lorbrena $44.93Loqtorzi $42.44Doptelet $41.96Tivdak $41.96Tecvayli $41.09Zynyz $40.79Itovebi $40.68Nerlynx $40.37Amtagvi $38.80Bosulif $37.55Pemazyre $34.02Gavreto $32.19Fyarro $32.15Fotivda $32.02Zoladex $31.70Odomzo $31.61Yonsa $31.61Empaveli $31.13Oxbryta $28.75Wayrilz $28.72Tecentriq Hybreza $28.01Keytruda Qlex $27.81Lonsurf $27.65Inqovi $27.65Tgct $26.31Beleodaq $25.64Elitek $25.05Krazati $24.82Imfinzi $24.28
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pramod Gaudel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.